In a filing, Vir Biotechnology Inc revealed its EVP and General Counsel de Verneuil Vanina unloaded Company’s shares for reported $67402.0 on Feb 26 ’25. In the deal valued at $9.14 per share,7,373 shares were sold. As a result of this transaction, de Verneuil Vanina now holds 79,460 shares worth roughly $0.65 million.
Then, VANINA DE VERNEUIL bought 7,373 shares, generating $67,094 in total proceeds.
Before that, SCANGOS GEORGE A sold 10,056 shares. Vir Biotechnology Inc shares valued at $95,063 were divested by the Director at a price of $9.45 per share. As a result of the transaction, SCANGOS GEORGE A now holds 698,239 shares, worth roughly $5.73 million.
JP Morgan downgraded its Vir Biotechnology Inc [VIR] rating to a Neutral from a an Overweight in a research note published on January 29, 2024; the price target was decreased to $9 from $23. A number of analysts have revised their coverage, including BofA Securities’s analysts, who decreased its forecast for the stock in early September from “a Buy” to “a Neutral”. JP Morgan also remained covering VIR and has increased its forecast on March 06, 2023 with a “an Overweight” recommendation from previously “Neutral” rating. Goldman revised its rating on February 21, 2023. It rated VIR as “a Buy” which previously was an “a Neutral”.
Price Performance Review of VIR
On Tuesday, Vir Biotechnology Inc [NASDAQ:VIR] saw its stock jump 3.54% to $8.20. Over the last five days, the stock has lost -9.89%. Vir Biotechnology Inc shares have risen nearly 11.72% since the year began. Nevertheless, the stocks have fallen -27.05% over the past one year. While a 52-week high of $14.45 was reached on 01/08/25, a 52-week low of $6.56 was recorded on 01/03/25. SMA at 50 days reached $9.28, while 200 days put it at $8.87.
Levels Of Support And Resistance For VIR Stock
The 24-hour chart illustrates a support level at 7.75, which if violated will result in even more drops to 7.31. On the upside, there is a resistance level at 8.50. A further resistance level may holdings at 8.81. The Relative Strength Index (RSI) on the 14-day chart is 38.28, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.95, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 75.42%. Stochastics %K at 18.51% indicates the stock is a buying.
